COVID-19 Coronavirus and Influenza A/B virus Real-Time PCR Kit are an In Vitro Diagnostic (IVD) reagent relying on fluorescent PCR technology for the qualitatively detection and differentiation of RNA from SARS-CoV-2, influenza A virus, and/or influenza B virus from upper and lower respiratory tract samples. Upper and lower respiratory tract samples include throat swab and sputum.
Key Points:
- Target region: Influenza A and Influenza B specific RNA
- Clinical Sensitivity: 96.1% (Flu A) 97.5% (Flu B)
- Clinical Specificity: 98.7% (Flu A) 98.2% (Flu B)
- Limit of detection: 2.0 TCID50/mL
- Sample input volume: 5μL
- Sample type: RNA in clinical specimens, including throat swab, nasal and pharyngeal secretions and cell culture supernatant
